Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer von Cortes, Javier, Rugo, Hope S., Cescon, David W., Im, Seock-Ah, Yusof, Mastura M., Gallardo, Carlos, Lipatov, Oleg, Barrios, Carlos H., Perez-Garcia, Jose, Iwata, Hiroji, Masuda, Norikazu, Torregroza Otero, Marco, Gokmen, Erhan, Loi, Sherene, Guo, Zifang, Zhou, Xuan, Karantza, Vassiliki, Pan, Wilbur, Schmid, Peter

Volltext

LBA16 KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC von Cortés, J., Cescon, D.W., Rugo, H.S., Im, S-A., Md Yusof, M., Gallardo, C., Lipatov, O., Barrios, C.H., Perez-Garcia, J., Iwata, H., Masuda, N., Torregroza Otero, M., Gokmen, E., Loi, S., Guo, Z., Zhou, X., Karantza, V., Pan, W., Schmid, P.

Volltext

164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (... von Cescon, D.W., Schmid, P., Rugo, H.S., Im, S-A., Md Yusof, M., Gallardo, C.E., Lipatov, O., Barrios, C.H., Perez Garcia, J.M., Iwata, H., Masuda, N., Torregroza Otero, M.A., Gokmen, E., Loi, S., Haiderali, A., Zhou, X., Guo, Z., Martin Nguyen, A., Cortés, J.

Volltext

191MO KEYNOTE-355: Outcomes in patients who discontinued chemotherapy before pembrolizumab and in patients with immune-mediated AEs von Rugo, H.S., Cescon, D.W., Im, S-A., Yusof, M. Md, Araneda, C.E. Gallardo, Lipatov, O., Cruz, F., Barrios, C.H., Hegg, R., Martín, E. Holgado, Torregroza Otero, M.A., Turner, N., Árkosy, P.F., Tarnawski, R., Karantza, V., Pan, W., Guo, Z., Cortés, J.

Volltext

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Tria... von Moore, Kathleen, Sundborg, Michael, Nishio, Shin, Wang, Ke, Kreynina, Julya, Lim, Sheow Lei, Bourhaba, Maryam, Ge, Lou, Gordinier, Mary, Jordan, Scott, Aktas, Bahriye, Gupta, Sudeep, Kim, Young, Devinder, Paul, Mccollum, Michael, Papadimitriou, Christos, Krabisch, Petra, Moroney, John, Poka, Robert, Goyal, Lovenish, Sipocz, Istvan, Guiling, Li, Onstad, Michaela, Denys, Hannelore, Sobol, Urszula, Edraki, Babak, Starks, David, Jonuskiene, Goda, Teplinsky, Eleonora, Takehara, Kazuhiro, Contreras Mejia, Fernando, Muller, Andreas, Nieuwenhuysen, Els van, Safra, Tamar, Martins Vieira, Carolina, Mattar, Andre, Ryu, Sang Young, Covens, Allan, Guerke, Lara de, Hong, Zheng, Lau, Susie, Hamanishi, Junzo, Hongwu, Wen, Wimberger, Pauline, Jing, Wang, Li, Wang, Suso, Juan Pablo, Gerson-Cwilich, Raquel, Qinglei, Gao, Songling, Zhang, Garza, Joseph de la, Wuliang, Wang, Alarcón Company, Jesús, Sánchez Villegas, Tomas, Pennington, Kathryn, Ho, Wing Ming, Leibovici, Anca, Liu, Ji-Hong, Landherr, Laszlo, Ozair, Sobia, Kado, Nobuhiro, Mileshkin, Linda, Kamiura, Shoji, Vettus, Elen, Rose, Peter, Pfaendler, Krista, Mori, Masahiko, Martinez Lira, José Luís, Yunokawa, Mayu, Meniawy, Tarek, Gao, Bo, Fleming, Evelyn, Priebe, Anna, Bednarek, Wieslawa, Blank, Stephanie V, Congzhu, Li, Potemski, Piotr, Sperfeld, Antje, Cuypere, Eveline de, Sikorska, Magdalena, Richardson, Gary, Hong, Sook Hee, Shao Peng, David Tan, Kim, Jan-Weon, Resnick, Kimberly, Torregroza Otero, Marco Antonio, Baurain, Jean Francois, Yin, Rutie, Hong, Shi, Costa Miranda, Vanessa da, Anderson, Charles, Danbo, Wang, Berman, Tara, Blank, Stephanie, Gold, Michael, Burke, James, Grisan, Karin, Cappuccini, Fabio, Ying, Cheng, Guedes, Joao Daniel

Volltext